Aliaksandr Bulhak

402 total citations
8 papers, 364 citations indexed

About

Aliaksandr Bulhak is a scholar working on Pathology and Forensic Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Aliaksandr Bulhak has authored 8 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Aliaksandr Bulhak's work include Cardiac Ischemia and Reperfusion (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac Arrest and Resuscitation (2 papers). Aliaksandr Bulhak is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac Arrest and Resuscitation (2 papers). Aliaksandr Bulhak collaborates with scholars based in Sweden. Aliaksandr Bulhak's co-authors include John Pernow, Per‐Ove Sjöquist, P.‐O. Sjöquist, Adrian Gonon, Jon O. Lundberg, Christian Jung, Claes‐Göran Östenson, Lars Edvinsson, Cang‐Bao Xu and Jonas Persson and has published in prestigious journals such as British Journal of Pharmacology, Cardiovascular Research and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Aliaksandr Bulhak

8 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aliaksandr Bulhak Sweden 7 150 127 118 111 59 8 364
Ya Xu United States 14 241 1.6× 208 1.6× 93 0.8× 72 0.6× 39 0.7× 24 500
Alfonso Antonio Taccardi Italy 11 101 0.7× 161 1.3× 101 0.9× 99 0.9× 23 0.4× 17 435
G. Gaia Italy 11 231 1.5× 248 2.0× 125 1.1× 148 1.3× 23 0.4× 18 562
Carmem Luíza Sartório Brazil 12 164 1.1× 187 1.5× 104 0.9× 118 1.1× 28 0.5× 30 483
Robert M. Osipov United States 13 179 1.2× 153 1.2× 154 1.3× 161 1.5× 72 1.2× 20 594
Shujian Wei China 13 204 1.4× 103 0.8× 63 0.5× 136 1.2× 128 2.2× 28 493
Yuzo Akita Japan 12 225 1.5× 144 1.1× 72 0.6× 113 1.0× 15 0.3× 26 417
X. L. United States 13 161 1.1× 178 1.4× 216 1.8× 214 1.9× 30 0.5× 13 569
Brian Siu Hong Kong 6 243 1.6× 83 0.7× 109 0.9× 163 1.5× 27 0.5× 17 512
Judit Pipis Hungary 11 112 0.7× 111 0.9× 63 0.5× 146 1.3× 23 0.4× 18 328

Countries citing papers authored by Aliaksandr Bulhak

Since Specialization
Citations

This map shows the geographic impact of Aliaksandr Bulhak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliaksandr Bulhak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliaksandr Bulhak more than expected).

Fields of papers citing papers by Aliaksandr Bulhak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aliaksandr Bulhak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliaksandr Bulhak. The network helps show where Aliaksandr Bulhak may publish in the future.

Co-authorship network of co-authors of Aliaksandr Bulhak

This figure shows the co-authorship network connecting the top 25 collaborators of Aliaksandr Bulhak. A scholar is included among the top collaborators of Aliaksandr Bulhak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aliaksandr Bulhak. Aliaksandr Bulhak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pehrson, Rikard & Aliaksandr Bulhak. (2012). Respiration rate derived from ECG in dogs. Journal of Pharmacological and Toxicological Methods. 66(2). 183–183. 1 indexed citations
2.
Bulhak, Aliaksandr, Christian Jung, Claes‐Göran Östenson, et al.. (2009). PPAR-α activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. American Journal of Physiology-Heart and Circulatory Physiology. 296(3). H719–H727. 108 indexed citations
3.
Gonon, Adrian, Ulrika Widegren, Aliaksandr Bulhak, et al.. (2008). Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovascular Research. 78(1). 116–122. 71 indexed citations
4.
Bulhak, Aliaksandr, Joy Roy, Ulf Hedin, Per‐Ove Sjöquist, & John Pernow. (2007). Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation. American Journal of Physiology-Heart and Circulatory Physiology. 292(6). H3158–H3163. 41 indexed citations
5.
Bulhak, Aliaksandr, P.‐O. Sjöquist, Cang‐Bao Xu, Lars Edvinsson, & John Pernow. (2006). Protection against myocardial ischaemia/reperfusion injury by PPAR–α activation is related to production of nitric oxide and endothelin–1. Basic Research in Cardiology. 101(3). 244–252. 56 indexed citations
6.
Bulhak, Aliaksandr, A. V. Gourine, Adrian Gonon, et al.. (2005). Oral pre‐treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level. Acta Physiologica Scandinavica. 183(2). 151–159. 30 indexed citations
8.
Gourine, Andrey, Aliaksandr Bulhak, Adrian Gonon, John Pernow, & Per‐Ove Sjöquist. (2002). Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia–reperfusion in vivo. Nitric Oxide. 7(3). 210–216. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026